nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCB1—ulcerative colitis	0.18	1	CbGaD
Lansoprazole—CYP4A11—Dexamethasone—ulcerative colitis	0.0719	0.132	CbGbCtD
Lansoprazole—CYP1A1—Nicotine—ulcerative colitis	0.0337	0.0618	CbGbCtD
Lansoprazole—CYP1A1—Cholecalciferol—ulcerative colitis	0.0303	0.0554	CbGbCtD
Lansoprazole—CYP1B1—Dexamethasone—ulcerative colitis	0.0298	0.0546	CbGbCtD
Lansoprazole—ABCG2—Sulfasalazine—ulcerative colitis	0.0284	0.052	CbGbCtD
Lansoprazole—ATP4A—gastric juice—ulcerative colitis	0.0265	0.499	CbGeAlD
Lansoprazole—ABCG2—Hydrocortisone—ulcerative colitis	0.0228	0.0418	CbGbCtD
Lansoprazole—CYP2C8—Nicotine—ulcerative colitis	0.0195	0.0357	CbGbCtD
Lansoprazole—CYP3A4—Budesonide—ulcerative colitis	0.0181	0.0332	CbGbCtD
Lansoprazole—CYP2C8—Cholecalciferol—ulcerative colitis	0.0175	0.032	CbGbCtD
Lansoprazole—CYP2C19—Nicotine—ulcerative colitis	0.0163	0.0299	CbGbCtD
Lansoprazole—CYP1A2—Nicotine—ulcerative colitis	0.0151	0.0276	CbGbCtD
Lansoprazole—CYP2C19—Cholecalciferol—ulcerative colitis	0.0147	0.0268	CbGbCtD
Lansoprazole—ABCG2—Dexamethasone—ulcerative colitis	0.0142	0.026	CbGbCtD
Lansoprazole—CYP2C9—Nicotine—ulcerative colitis	0.0136	0.0249	CbGbCtD
Lansoprazole—ABCB1—Methylprednisolone—ulcerative colitis	0.0135	0.0248	CbGbCtD
Lansoprazole—CYP1A1—Dexamethasone—ulcerative colitis	0.0131	0.024	CbGbCtD
Lansoprazole—CYP2D6—Nicotine—ulcerative colitis	0.0124	0.0227	CbGbCtD
Lansoprazole—CYP2C9—Cholecalciferol—ulcerative colitis	0.0122	0.0223	CbGbCtD
Lansoprazole—CYP2C8—Hydrocortisone—ulcerative colitis	0.0122	0.0222	CbGbCtD
Lansoprazole—CYP2D6—Cholecalciferol—ulcerative colitis	0.0111	0.0204	CbGbCtD
Lansoprazole—CYP2C19—Prednisone—ulcerative colitis	0.0102	0.0186	CbGbCtD
Lansoprazole—ABCB1—Betamethasone—ulcerative colitis	0.00879	0.0161	CbGbCtD
Lansoprazole—ABCB1—Prednisolone—ulcerative colitis	0.00868	0.0159	CbGbCtD
Lansoprazole—ABCB1—Hydrocortisone—ulcerative colitis	0.00823	0.0151	CbGbCtD
Lansoprazole—ABCB1—Prednisone—ulcerative colitis	0.00819	0.015	CbGbCtD
Lansoprazole—CYP3A4—Methylprednisolone—ulcerative colitis	0.0081	0.0148	CbGbCtD
Lansoprazole—CYP3A4—Nicotine—ulcerative colitis	0.0079	0.0145	CbGbCtD
Lansoprazole—CYP2C8—Dexamethasone—ulcerative colitis	0.00756	0.0138	CbGbCtD
Lansoprazole—CYP3A4—Cholecalciferol—ulcerative colitis	0.00708	0.013	CbGbCtD
Lansoprazole—CYP2C19—Dexamethasone—ulcerative colitis	0.00634	0.0116	CbGbCtD
Lansoprazole—CYP3A4—Triamcinolone—ulcerative colitis	0.00614	0.0112	CbGbCtD
Lansoprazole—CYP2C9—Dexamethasone—ulcerative colitis	0.00527	0.00965	CbGbCtD
Lansoprazole—CYP3A4—Betamethasone—ulcerative colitis	0.00527	0.00965	CbGbCtD
Lansoprazole—CYP3A4—Prednisolone—ulcerative colitis	0.0052	0.00952	CbGbCtD
Lansoprazole—ABCB1—Dexamethasone—ulcerative colitis	0.00512	0.00937	CbGbCtD
Lansoprazole—CYP3A4—Hydrocortisone—ulcerative colitis	0.00493	0.00902	CbGbCtD
Lansoprazole—CYP3A4—Prednisone—ulcerative colitis	0.00491	0.00899	CbGbCtD
Lansoprazole—CYP2D6—Dexamethasone—ulcerative colitis	0.00482	0.00882	CbGbCtD
Lansoprazole—ATP4B—digestive system—ulcerative colitis	0.00372	0.0699	CbGeAlD
Lansoprazole—CYP3A4—Dexamethasone—ulcerative colitis	0.00307	0.00561	CbGbCtD
Lansoprazole—ATP4B—liver—ulcerative colitis	0.00277	0.0521	CbGeAlD
Lansoprazole—ATP4A—epithelium—ulcerative colitis	0.00213	0.04	CbGeAlD
Lansoprazole—CYP4A11—digestive system—ulcerative colitis	0.00201	0.0377	CbGeAlD
Lansoprazole—ATP4A—digestive system—ulcerative colitis	0.00162	0.0304	CbGeAlD
Lansoprazole—CYP4A11—liver—ulcerative colitis	0.0015	0.0281	CbGeAlD
Lansoprazole—CYP2C18—digestive system—ulcerative colitis	0.00133	0.025	CbGeAlD
Lansoprazole—ATP4A—liver—ulcerative colitis	0.00121	0.0227	CbGeAlD
Lansoprazole—CYP2C18—liver—ulcerative colitis	0.000991	0.0186	CbGeAlD
Lansoprazole—CYP1B1—smooth muscle tissue—ulcerative colitis	0.000816	0.0153	CbGeAlD
Lansoprazole—CYP1B1—lymphoid tissue—ulcerative colitis	0.000652	0.0123	CbGeAlD
Lansoprazole—CYP1B1—digestive system—ulcerative colitis	0.000644	0.0121	CbGeAlD
Lansoprazole—CYP1A1—epithelium—ulcerative colitis	0.000599	0.0113	CbGeAlD
Lansoprazole—CYP2C19—digestive system—ulcerative colitis	0.000565	0.0106	CbGeAlD
Lansoprazole—CYP1B1—liver—ulcerative colitis	0.00048	0.00902	CbGeAlD
Lansoprazole—CYP1A2—digestive system—ulcerative colitis	0.000462	0.00868	CbGeAlD
Lansoprazole—CYP1A1—digestive system—ulcerative colitis	0.000456	0.00856	CbGeAlD
Lansoprazole—CYP2C9—digestive system—ulcerative colitis	0.000438	0.00824	CbGeAlD
Lansoprazole—CYP2C19—liver—ulcerative colitis	0.000421	0.00792	CbGeAlD
Lansoprazole—CYP2C8—liver—ulcerative colitis	0.000368	0.00691	CbGeAlD
Lansoprazole—ABCG2—liver—ulcerative colitis	0.000358	0.00672	CbGeAlD
Lansoprazole—CYP1A2—liver—ulcerative colitis	0.000344	0.00647	CbGeAlD
Lansoprazole—CYP1A1—liver—ulcerative colitis	0.000339	0.00638	CbGeAlD
Lansoprazole—CYP3A4—digestive system—ulcerative colitis	0.000334	0.00628	CbGeAlD
Lansoprazole—CYP2D6—digestive system—ulcerative colitis	0.000329	0.00618	CbGeAlD
Lansoprazole—CYP2C9—liver—ulcerative colitis	0.000327	0.00614	CbGeAlD
Lansoprazole—ABCB1—epithelium—ulcerative colitis	0.000311	0.00585	CbGeAlD
Lansoprazole—Pantoprazole—ABCB1—ulcerative colitis	0.000296	0.551	CrCbGaD
Lansoprazole—CYP3A4—liver—ulcerative colitis	0.000249	0.00468	CbGeAlD
Lansoprazole—CYP2D6—liver—ulcerative colitis	0.000245	0.00461	CbGeAlD
Lansoprazole—Omeprazole—ABCB1—ulcerative colitis	0.000241	0.449	CrCbGaD
Lansoprazole—ABCB1—lymphoid tissue—ulcerative colitis	0.00024	0.0045	CbGeAlD
Lansoprazole—ABCB1—digestive system—ulcerative colitis	0.000237	0.00445	CbGeAlD
Lansoprazole—ABCB1—liver—ulcerative colitis	0.000176	0.00331	CbGeAlD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	7.59e-05	0.00309	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	7.55e-05	0.00307	CbGpPWpGaD
Lansoprazole—CYP1B1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	7.46e-05	0.00303	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—NFKB1—ulcerative colitis	7.44e-05	0.00303	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	7.42e-05	0.00302	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	7.39e-05	0.00301	CbGpPWpGaD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.28e-05	0.00296	CbGpPWpGaD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.27e-05	0.00296	CbGpPWpGaD
Lansoprazole—CYP1B1—Biological oxidations—PTGS1—ulcerative colitis	7.24e-05	0.00295	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	7.22e-05	0.00294	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—IL1B—ulcerative colitis	7.05e-05	0.00287	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	7e-05	0.00285	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	6.92e-05	0.00281	CbGpPWpGaD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.87e-05	0.00279	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	6.84e-05	0.00278	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.73e-05	0.00274	CbGpPWpGaD
Lansoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	6.71e-05	0.00273	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—STAT3—ulcerative colitis	6.69e-05	0.00272	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	6.64e-05	0.0027	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—NFKB1—ulcerative colitis	6.58e-05	0.00268	CbGpPWpGaD
Lansoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.35e-05	0.00258	CbGpPWpGaD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.32e-05	0.00257	CbGpPWpGaD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.26e-05	0.00255	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	6.17e-05	0.00251	CbGpPWpGaD
Lansoprazole—CYP1A1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	6.16e-05	0.00251	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidative Stress—NFKB1—ulcerative colitis	6e-05	0.00244	CbGpPWpGaD
Lansoprazole—Arthralgia—Methylprednisolone—ulcerative colitis	5.97e-05	0.000306	CcSEcCtD
Lansoprazole—Eye disorder—Prednisone—ulcerative colitis	5.96e-05	0.000305	CcSEcCtD
Lansoprazole—Anxiety—Methylprednisolone—ulcerative colitis	5.95e-05	0.000305	CcSEcCtD
Lansoprazole—Tachycardia—Hydrocortisone—ulcerative colitis	5.94e-05	0.000305	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	5.94e-05	0.00242	CbGpPWpGaD
Lansoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.93e-05	0.00241	CbGpPWpGaD
Lansoprazole—Rash—Azathioprine—ulcerative colitis	5.93e-05	0.000304	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	5.92e-05	0.000304	CcSEcCtD
Lansoprazole—Dermatitis—Azathioprine—ulcerative colitis	5.92e-05	0.000303	CcSEcCtD
Lansoprazole—Skin disorder—Hydrocortisone—ulcerative colitis	5.91e-05	0.000303	CcSEcCtD
Lansoprazole—Ill-defined disorder—Betamethasone—ulcerative colitis	5.91e-05	0.000303	CcSEcCtD
Lansoprazole—Ill-defined disorder—Dexamethasone—ulcerative colitis	5.91e-05	0.000303	CcSEcCtD
Lansoprazole—Discomfort—Triamcinolone—ulcerative colitis	5.91e-05	0.000303	CcSEcCtD
Lansoprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	5.9e-05	0.0024	CbGpPWpGaD
Lansoprazole—Discomfort—Methylprednisolone—ulcerative colitis	5.89e-05	0.000302	CcSEcCtD
Lansoprazole—Headache—Azathioprine—ulcerative colitis	5.89e-05	0.000302	CcSEcCtD
Lansoprazole—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.88e-05	0.000302	CcSEcCtD
Lansoprazole—Diarrhoea—Mesalazine—ulcerative colitis	5.86e-05	0.0003	CcSEcCtD
Lansoprazole—Dry mouth—Triamcinolone—ulcerative colitis	5.85e-05	0.0003	CcSEcCtD
Lansoprazole—Angioedema—Dexamethasone—ulcerative colitis	5.82e-05	0.000298	CcSEcCtD
Lansoprazole—Angioedema—Betamethasone—ulcerative colitis	5.82e-05	0.000298	CcSEcCtD
Lansoprazole—Anorexia—Hydrocortisone—ulcerative colitis	5.8e-05	0.000297	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	5.8e-05	0.00236	CbGpPWpGaD
Lansoprazole—Angiopathy—Prednisone—ulcerative colitis	5.78e-05	0.000296	CcSEcCtD
Lansoprazole—Confusional state—Methylprednisolone—ulcerative colitis	5.77e-05	0.000296	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	5.76e-05	0.00234	CbGpPWpGaD
Lansoprazole—Immune system disorder—Prednisone—ulcerative colitis	5.76e-05	0.000295	CcSEcCtD
Lansoprazole—Malaise—Dexamethasone—ulcerative colitis	5.75e-05	0.000295	CcSEcCtD
Lansoprazole—Malaise—Betamethasone—ulcerative colitis	5.75e-05	0.000295	CcSEcCtD
Lansoprazole—Oedema—Triamcinolone—ulcerative colitis	5.73e-05	0.000294	CcSEcCtD
Lansoprazole—Anaphylactic shock—Triamcinolone—ulcerative colitis	5.73e-05	0.000294	CcSEcCtD
Lansoprazole—Vertigo—Betamethasone—ulcerative colitis	5.73e-05	0.000293	CcSEcCtD
Lansoprazole—Vertigo—Dexamethasone—ulcerative colitis	5.73e-05	0.000293	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methylprednisolone—ulcerative colitis	5.72e-05	0.000293	CcSEcCtD
Lansoprazole—Syncope—Dexamethasone—ulcerative colitis	5.71e-05	0.000293	CcSEcCtD
Lansoprazole—Syncope—Betamethasone—ulcerative colitis	5.71e-05	0.000293	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisone—ulcerative colitis	5.7e-05	0.000292	CcSEcCtD
Lansoprazole—Infection—Triamcinolone—ulcerative colitis	5.69e-05	0.000292	CcSEcCtD
Lansoprazole—Hypotension—Hydrocortisone—ulcerative colitis	5.69e-05	0.000292	CcSEcCtD
Lansoprazole—Infection—Methylprednisolone—ulcerative colitis	5.68e-05	0.000291	CcSEcCtD
Lansoprazole—Dizziness—Mesalazine—ulcerative colitis	5.66e-05	0.00029	CcSEcCtD
Lansoprazole—Shock—Triamcinolone—ulcerative colitis	5.64e-05	0.000289	CcSEcCtD
Lansoprazole—Insomnia—Prednisolone—ulcerative colitis	5.64e-05	0.000289	CcSEcCtD
Lansoprazole—Alopecia—Prednisone—ulcerative colitis	5.63e-05	0.000289	CcSEcCtD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	5.63e-05	0.00229	CbGpPWpGaD
Lansoprazole—Shock—Methylprednisolone—ulcerative colitis	5.63e-05	0.000288	CcSEcCtD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.62e-05	0.00229	CbGpPWpGaD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.61e-05	0.00228	CbGpPWpGaD
Lansoprazole—Nervous system disorder—Methylprednisolone—ulcerative colitis	5.61e-05	0.000287	CcSEcCtD
Lansoprazole—Loss of consciousness—Betamethasone—ulcerative colitis	5.6e-05	0.000287	CcSEcCtD
Lansoprazole—Loss of consciousness—Dexamethasone—ulcerative colitis	5.6e-05	0.000287	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisolone—ulcerative colitis	5.6e-05	0.000287	CcSEcCtD
Lansoprazole—Tachycardia—Triamcinolone—ulcerative colitis	5.59e-05	0.000287	CcSEcCtD
Lansoprazole—Mental disorder—Prednisone—ulcerative colitis	5.59e-05	0.000286	CcSEcCtD
Lansoprazole—Nausea—Azathioprine—ulcerative colitis	5.58e-05	0.000286	CcSEcCtD
Lansoprazole—Tachycardia—Methylprednisolone—ulcerative colitis	5.58e-05	0.000286	CcSEcCtD
Lansoprazole—Skin disorder—Methylprednisolone—ulcerative colitis	5.56e-05	0.000285	CcSEcCtD
Lansoprazole—Malnutrition—Prednisone—ulcerative colitis	5.55e-05	0.000284	CcSEcCtD
Lansoprazole—Erythema—Prednisone—ulcerative colitis	5.55e-05	0.000284	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	5.55e-05	0.000284	CcSEcCtD
Lansoprazole—Hyperhidrosis—Triamcinolone—ulcerative colitis	5.54e-05	0.000284	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methylprednisolone—ulcerative colitis	5.53e-05	0.000283	CcSEcCtD
Lansoprazole—Convulsion—Dexamethasone—ulcerative colitis	5.52e-05	0.000283	CcSEcCtD
Lansoprazole—Convulsion—Betamethasone—ulcerative colitis	5.52e-05	0.000283	CcSEcCtD
Lansoprazole—Insomnia—Hydrocortisone—ulcerative colitis	5.51e-05	0.000282	CcSEcCtD
Lansoprazole—Hypertension—Dexamethasone—ulcerative colitis	5.5e-05	0.000282	CcSEcCtD
Lansoprazole—Hypertension—Betamethasone—ulcerative colitis	5.5e-05	0.000282	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—TGFB1—ulcerative colitis	5.48e-05	0.00223	CbGpPWpGaD
Lansoprazole—Paraesthesia—Hydrocortisone—ulcerative colitis	5.47e-05	0.00028	CcSEcCtD
Lansoprazole—MAPT—Apoptosis—TNF—ulcerative colitis	5.46e-05	0.00222	CbGpPWpGaD
Lansoprazole—Vomiting—Mesalazine—ulcerative colitis	5.44e-05	0.000279	CcSEcCtD
Lansoprazole—Myalgia—Betamethasone—ulcerative colitis	5.43e-05	0.000278	CcSEcCtD
Lansoprazole—Myalgia—Dexamethasone—ulcerative colitis	5.43e-05	0.000278	CcSEcCtD
Lansoprazole—Anxiety—Betamethasone—ulcerative colitis	5.41e-05	0.000277	CcSEcCtD
Lansoprazole—Anxiety—Dexamethasone—ulcerative colitis	5.41e-05	0.000277	CcSEcCtD
Lansoprazole—Rash—Mesalazine—ulcerative colitis	5.4e-05	0.000277	CcSEcCtD
Lansoprazole—Dermatitis—Mesalazine—ulcerative colitis	5.39e-05	0.000276	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	5.38e-05	0.00219	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	5.38e-05	0.00219	CbGpPWpGaD
Lansoprazole—Headache—Mesalazine—ulcerative colitis	5.36e-05	0.000275	CcSEcCtD
Lansoprazole—Discomfort—Dexamethasone—ulcerative colitis	5.36e-05	0.000275	CcSEcCtD
Lansoprazole—Discomfort—Betamethasone—ulcerative colitis	5.36e-05	0.000275	CcSEcCtD
Lansoprazole—Dyspepsia—Hydrocortisone—ulcerative colitis	5.36e-05	0.000275	CcSEcCtD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.35e-05	0.00218	CbGpPWpGaD
Lansoprazole—Hypotension—Methylprednisolone—ulcerative colitis	5.34e-05	0.000274	CcSEcCtD
Lansoprazole—Pain—Prednisolone—ulcerative colitis	5.33e-05	0.000273	CcSEcCtD
Lansoprazole—Decreased appetite—Hydrocortisone—ulcerative colitis	5.29e-05	0.000271	CcSEcCtD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	5.28e-05	0.00215	CbGpPWpGaD
Lansoprazole—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	5.26e-05	0.000269	CcSEcCtD
Lansoprazole—Fatigue—Hydrocortisone—ulcerative colitis	5.25e-05	0.000269	CcSEcCtD
Lansoprazole—Vision blurred—Prednisone—ulcerative colitis	5.23e-05	0.000268	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	5.22e-05	0.000268	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	5.21e-05	0.000267	CcSEcCtD
Lansoprazole—Pain—Hydrocortisone—ulcerative colitis	5.21e-05	0.000267	CcSEcCtD
Lansoprazole—Oedema—Betamethasone—ulcerative colitis	5.2e-05	0.000267	CcSEcCtD
Lansoprazole—Oedema—Dexamethasone—ulcerative colitis	5.2e-05	0.000267	CcSEcCtD
Lansoprazole—Anaphylactic shock—Betamethasone—ulcerative colitis	5.2e-05	0.000267	CcSEcCtD
Lansoprazole—Anaphylactic shock—Dexamethasone—ulcerative colitis	5.2e-05	0.000267	CcSEcCtD
Lansoprazole—Insomnia—Triamcinolone—ulcerative colitis	5.18e-05	0.000266	CcSEcCtD
Lansoprazole—Insomnia—Methylprednisolone—ulcerative colitis	5.17e-05	0.000265	CcSEcCtD
Lansoprazole—Infection—Dexamethasone—ulcerative colitis	5.17e-05	0.000265	CcSEcCtD
Lansoprazole—Infection—Betamethasone—ulcerative colitis	5.17e-05	0.000265	CcSEcCtD
Lansoprazole—Ill-defined disorder—Prednisone—ulcerative colitis	5.15e-05	0.000264	CcSEcCtD
Lansoprazole—Paraesthesia—Triamcinolone—ulcerative colitis	5.15e-05	0.000264	CcSEcCtD
Lansoprazole—Feeling abnormal—Prednisolone—ulcerative colitis	5.14e-05	0.000263	CcSEcCtD
Lansoprazole—Paraesthesia—Methylprednisolone—ulcerative colitis	5.14e-05	0.000263	CcSEcCtD
Lansoprazole—Anaemia—Prednisone—ulcerative colitis	5.13e-05	0.000263	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	5.12e-05	0.00208	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—ulcerative colitis	5.12e-05	0.00208	CbGpPWpGaD
Lansoprazole—Shock—Betamethasone—ulcerative colitis	5.12e-05	0.000262	CcSEcCtD
Lansoprazole—Shock—Dexamethasone—ulcerative colitis	5.12e-05	0.000262	CcSEcCtD
Lansoprazole—Dyspnoea—Triamcinolone—ulcerative colitis	5.11e-05	0.000262	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	5.11e-05	0.00208	CbGpPWpGaD
Lansoprazole—Nervous system disorder—Dexamethasone—ulcerative colitis	5.1e-05	0.000261	CcSEcCtD
Lansoprazole—Nervous system disorder—Betamethasone—ulcerative colitis	5.1e-05	0.000261	CcSEcCtD
Lansoprazole—Agitation—Prednisone—ulcerative colitis	5.1e-05	0.000261	CcSEcCtD
Lansoprazole—Thrombocytopenia—Betamethasone—ulcerative colitis	5.09e-05	0.000261	CcSEcCtD
Lansoprazole—Thrombocytopenia—Dexamethasone—ulcerative colitis	5.09e-05	0.000261	CcSEcCtD
Lansoprazole—Nausea—Mesalazine—ulcerative colitis	5.08e-05	0.000261	CcSEcCtD
Lansoprazole—Tachycardia—Dexamethasone—ulcerative colitis	5.08e-05	0.00026	CcSEcCtD
Lansoprazole—Tachycardia—Betamethasone—ulcerative colitis	5.08e-05	0.00026	CcSEcCtD
Lansoprazole—Angioedema—Prednisone—ulcerative colitis	5.07e-05	0.00026	CcSEcCtD
Lansoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.07e-05	0.00206	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.07e-05	0.00206	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	5.05e-05	0.00206	CbGpPWpGaD
Lansoprazole—Dyspepsia—Triamcinolone—ulcerative colitis	5.05e-05	0.000259	CcSEcCtD
Lansoprazole—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.04e-05	0.00205	CbGpPWpGaD
Lansoprazole—Dyspepsia—Methylprednisolone—ulcerative colitis	5.03e-05	0.000258	CcSEcCtD
Lansoprazole—Hyperhidrosis—Betamethasone—ulcerative colitis	5.03e-05	0.000258	CcSEcCtD
Lansoprazole—Hyperhidrosis—Dexamethasone—ulcerative colitis	5.03e-05	0.000258	CcSEcCtD
Lansoprazole—Feeling abnormal—Hydrocortisone—ulcerative colitis	5.02e-05	0.000257	CcSEcCtD
Lansoprazole—Malaise—Prednisone—ulcerative colitis	5e-05	0.000257	CcSEcCtD
Lansoprazole—Vertigo—Prednisone—ulcerative colitis	4.99e-05	0.000256	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.98e-05	0.000255	CcSEcCtD
Lansoprazole—Syncope—Prednisone—ulcerative colitis	4.98e-05	0.000255	CcSEcCtD
Lansoprazole—Anorexia—Betamethasone—ulcerative colitis	4.96e-05	0.000254	CcSEcCtD
Lansoprazole—Anorexia—Dexamethasone—ulcerative colitis	4.96e-05	0.000254	CcSEcCtD
Lansoprazole—Urticaria—Prednisolone—ulcerative colitis	4.95e-05	0.000254	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	4.95e-05	0.00201	CbGpPWpGaD
Lansoprazole—Fatigue—Triamcinolone—ulcerative colitis	4.94e-05	0.000253	CcSEcCtD
Lansoprazole—Fatigue—Methylprednisolone—ulcerative colitis	4.93e-05	0.000253	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	4.91e-05	0.002	CbGpPWpGaD
Lansoprazole—Pain—Triamcinolone—ulcerative colitis	4.9e-05	0.000251	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisone—ulcerative colitis	4.88e-05	0.00025	CcSEcCtD
Lansoprazole—Hypotension—Dexamethasone—ulcerative colitis	4.86e-05	0.000249	CcSEcCtD
Lansoprazole—Hypotension—Betamethasone—ulcerative colitis	4.86e-05	0.000249	CcSEcCtD
Lansoprazole—Urticaria—Hydrocortisone—ulcerative colitis	4.84e-05	0.000248	CcSEcCtD
Lansoprazole—Body temperature increased—Hydrocortisone—ulcerative colitis	4.81e-05	0.000247	CcSEcCtD
Lansoprazole—Abdominal pain—Hydrocortisone—ulcerative colitis	4.81e-05	0.000247	CcSEcCtD
Lansoprazole—MAPT—Apoptosis—TP53—ulcerative colitis	4.81e-05	0.00196	CbGpPWpGaD
Lansoprazole—Convulsion—Prednisone—ulcerative colitis	4.81e-05	0.000246	CcSEcCtD
Lansoprazole—Hypertension—Prednisone—ulcerative colitis	4.79e-05	0.000246	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.74e-05	0.000243	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.74e-05	0.000243	CcSEcCtD
Lansoprazole—Myalgia—Prednisone—ulcerative colitis	4.72e-05	0.000242	CcSEcCtD
Lansoprazole—Arthralgia—Prednisone—ulcerative colitis	4.72e-05	0.000242	CcSEcCtD
Lansoprazole—Feeling abnormal—Triamcinolone—ulcerative colitis	4.72e-05	0.000242	CcSEcCtD
Lansoprazole—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.71e-05	0.000242	CcSEcCtD
Lansoprazole—Anxiety—Prednisone—ulcerative colitis	4.71e-05	0.000241	CcSEcCtD
Lansoprazole—Insomnia—Dexamethasone—ulcerative colitis	4.7e-05	0.000241	CcSEcCtD
Lansoprazole—Insomnia—Betamethasone—ulcerative colitis	4.7e-05	0.000241	CcSEcCtD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.7e-05	0.00191	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.7e-05	0.00191	CbGpPWpGaD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.69e-05	0.000241	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.68e-05	0.00024	CcSEcCtD
Lansoprazole—Paraesthesia—Dexamethasone—ulcerative colitis	4.67e-05	0.000239	CcSEcCtD
Lansoprazole—Paraesthesia—Betamethasone—ulcerative colitis	4.67e-05	0.000239	CcSEcCtD
Lansoprazole—Discomfort—Prednisone—ulcerative colitis	4.67e-05	0.000239	CcSEcCtD
Lansoprazole—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	4.64e-05	0.00189	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.62e-05	0.00188	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CHP1—ulcerative colitis	4.61e-05	0.00187	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Prednisolone—ulcerative colitis	4.59e-05	0.000235	CcSEcCtD
Lansoprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.59e-05	0.00187	CbGpPWpGaD
Lansoprazole—Dyspepsia—Dexamethasone—ulcerative colitis	4.58e-05	0.000235	CcSEcCtD
Lansoprazole—Dyspepsia—Betamethasone—ulcerative colitis	4.58e-05	0.000235	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	4.57e-05	0.00186	CbGpPWpGaD
Lansoprazole—Urticaria—Triamcinolone—ulcerative colitis	4.55e-05	0.000233	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	4.55e-05	0.00185	CbGpPWpGaD
Lansoprazole—Urticaria—Methylprednisolone—ulcerative colitis	4.54e-05	0.000233	CcSEcCtD
Lansoprazole—Body temperature increased—Triamcinolone—ulcerative colitis	4.53e-05	0.000232	CcSEcCtD
Lansoprazole—Oedema—Prednisone—ulcerative colitis	4.53e-05	0.000232	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisone—ulcerative colitis	4.53e-05	0.000232	CcSEcCtD
Lansoprazole—Abdominal pain—Methylprednisolone—ulcerative colitis	4.52e-05	0.000232	CcSEcCtD
Lansoprazole—Decreased appetite—Betamethasone—ulcerative colitis	4.52e-05	0.000232	CcSEcCtD
Lansoprazole—Decreased appetite—Dexamethasone—ulcerative colitis	4.52e-05	0.000232	CcSEcCtD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.51e-05	0.00184	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—ulcerative colitis	4.51e-05	0.00184	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—ulcerative colitis	4.51e-05	0.00184	CbGpPWpGaD
Lansoprazole—Infection—Prednisone—ulcerative colitis	4.5e-05	0.000231	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.49e-05	0.00023	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.49e-05	0.00023	CcSEcCtD
Lansoprazole—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.48e-05	0.00023	CcSEcCtD
Lansoprazole—Fatigue—Dexamethasone—ulcerative colitis	4.48e-05	0.00023	CcSEcCtD
Lansoprazole—Fatigue—Betamethasone—ulcerative colitis	4.48e-05	0.00023	CcSEcCtD
Lansoprazole—CYP1A1—Biological oxidations—PTGS1—ulcerative colitis	4.46e-05	0.00181	CbGpPWpGaD
Lansoprazole—Shock—Prednisone—ulcerative colitis	4.46e-05	0.000228	CcSEcCtD
Lansoprazole—Pain—Dexamethasone—ulcerative colitis	4.45e-05	0.000228	CcSEcCtD
Lansoprazole—Pain—Betamethasone—ulcerative colitis	4.45e-05	0.000228	CcSEcCtD
Lansoprazole—Nervous system disorder—Prednisone—ulcerative colitis	4.44e-05	0.000228	CcSEcCtD
Lansoprazole—Tachycardia—Prednisone—ulcerative colitis	4.42e-05	0.000227	CcSEcCtD
Lansoprazole—Skin disorder—Prednisone—ulcerative colitis	4.4e-05	0.000226	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisone—ulcerative colitis	4.38e-05	0.000224	CcSEcCtD
Lansoprazole—Asthenia—Hydrocortisone—ulcerative colitis	4.37e-05	0.000224	CcSEcCtD
Lansoprazole—Anorexia—Prednisone—ulcerative colitis	4.32e-05	0.000221	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.32e-05	0.00176	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	4.31e-05	0.00175	CbGpPWpGaD
Lansoprazole—Pruritus—Hydrocortisone—ulcerative colitis	4.31e-05	0.000221	CcSEcCtD
Lansoprazole—Feeling abnormal—Betamethasone—ulcerative colitis	4.29e-05	0.00022	CcSEcCtD
Lansoprazole—Feeling abnormal—Dexamethasone—ulcerative colitis	4.29e-05	0.00022	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	4.26e-05	0.00173	CbGpPWpGaD
Lansoprazole—Gastrointestinal pain—Dexamethasone—ulcerative colitis	4.25e-05	0.000218	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Betamethasone—ulcerative colitis	4.25e-05	0.000218	CcSEcCtD
Lansoprazole—Hypersensitivity—Triamcinolone—ulcerative colitis	4.22e-05	0.000216	CcSEcCtD
Lansoprazole—Hypersensitivity—Methylprednisolone—ulcerative colitis	4.21e-05	0.000216	CcSEcCtD
Lansoprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.21e-05	0.00171	CbGpPWpGaD
Lansoprazole—Diarrhoea—Hydrocortisone—ulcerative colitis	4.17e-05	0.000213	CcSEcCtD
Lansoprazole—Urticaria—Dexamethasone—ulcerative colitis	4.13e-05	0.000212	CcSEcCtD
Lansoprazole—Urticaria—Betamethasone—ulcerative colitis	4.13e-05	0.000212	CcSEcCtD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.13e-05	0.00168	CbGpPWpGaD
Lansoprazole—Musculoskeletal discomfort—Prednisone—ulcerative colitis	4.13e-05	0.000212	CcSEcCtD
Lansoprazole—Dizziness—Prednisolone—ulcerative colitis	4.12e-05	0.000211	CcSEcCtD
Lansoprazole—Asthenia—Triamcinolone—ulcerative colitis	4.11e-05	0.000211	CcSEcCtD
Lansoprazole—Body temperature increased—Dexamethasone—ulcerative colitis	4.11e-05	0.000211	CcSEcCtD
Lansoprazole—Abdominal pain—Betamethasone—ulcerative colitis	4.11e-05	0.000211	CcSEcCtD
Lansoprazole—Abdominal pain—Dexamethasone—ulcerative colitis	4.11e-05	0.000211	CcSEcCtD
Lansoprazole—Body temperature increased—Betamethasone—ulcerative colitis	4.11e-05	0.000211	CcSEcCtD
Lansoprazole—Asthenia—Methylprednisolone—ulcerative colitis	4.1e-05	0.00021	CcSEcCtD
Lansoprazole—Insomnia—Prednisone—ulcerative colitis	4.1e-05	0.00021	CcSEcCtD
Lansoprazole—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	4.09e-05	0.00166	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.07e-05	0.00166	CbGpPWpGaD
Lansoprazole—Paraesthesia—Prednisone—ulcerative colitis	4.07e-05	0.000208	CcSEcCtD
Lansoprazole—Pruritus—Triamcinolone—ulcerative colitis	4.06e-05	0.000208	CcSEcCtD
Lansoprazole—Pruritus—Methylprednisolone—ulcerative colitis	4.05e-05	0.000207	CcSEcCtD
Lansoprazole—Dizziness—Hydrocortisone—ulcerative colitis	4.03e-05	0.000206	CcSEcCtD
Lansoprazole—CYP2C18—Metabolism—CHP1—ulcerative colitis	4.03e-05	0.00164	CbGpPWpGaD
Lansoprazole—Dyspepsia—Prednisone—ulcerative colitis	3.99e-05	0.000204	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism—DLD—ulcerative colitis	3.98e-05	0.00162	CbGpPWpGaD
Lansoprazole—Decreased appetite—Prednisone—ulcerative colitis	3.94e-05	0.000202	CcSEcCtD
Lansoprazole—Rash—Prednisolone—ulcerative colitis	3.93e-05	0.000201	CcSEcCtD
Lansoprazole—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.93e-05	0.0016	CbGpPWpGaD
Lansoprazole—Dermatitis—Prednisolone—ulcerative colitis	3.93e-05	0.000201	CcSEcCtD
Lansoprazole—Diarrhoea—Methylprednisolone—ulcerative colitis	3.91e-05	0.000201	CcSEcCtD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.91e-05	0.00159	CbGpPWpGaD
Lansoprazole—Fatigue—Prednisone—ulcerative colitis	3.9e-05	0.0002	CcSEcCtD
Lansoprazole—Headache—Prednisolone—ulcerative colitis	3.9e-05	0.0002	CcSEcCtD
Lansoprazole—Constipation—Prednisone—ulcerative colitis	3.87e-05	0.000199	CcSEcCtD
Lansoprazole—Vomiting—Hydrocortisone—ulcerative colitis	3.87e-05	0.000198	CcSEcCtD
Lansoprazole—Rash—Hydrocortisone—ulcerative colitis	3.84e-05	0.000197	CcSEcCtD
Lansoprazole—Dermatitis—Hydrocortisone—ulcerative colitis	3.83e-05	0.000197	CcSEcCtD
Lansoprazole—Headache—Hydrocortisone—ulcerative colitis	3.81e-05	0.000195	CcSEcCtD
Lansoprazole—Dizziness—Triamcinolone—ulcerative colitis	3.79e-05	0.000194	CcSEcCtD
Lansoprazole—Dizziness—Methylprednisolone—ulcerative colitis	3.78e-05	0.000194	CcSEcCtD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.76e-05	0.00153	CbGpPWpGaD
Lansoprazole—Feeling abnormal—Prednisone—ulcerative colitis	3.73e-05	0.000191	CcSEcCtD
Lansoprazole—Asthenia—Dexamethasone—ulcerative colitis	3.73e-05	0.000191	CcSEcCtD
Lansoprazole—Asthenia—Betamethasone—ulcerative colitis	3.73e-05	0.000191	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Prednisone—ulcerative colitis	3.7e-05	0.00019	CcSEcCtD
Lansoprazole—Nausea—Prednisolone—ulcerative colitis	3.7e-05	0.00019	CcSEcCtD
Lansoprazole—Pruritus—Dexamethasone—ulcerative colitis	3.68e-05	0.000189	CcSEcCtD
Lansoprazole—Pruritus—Betamethasone—ulcerative colitis	3.68e-05	0.000189	CcSEcCtD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	3.67e-05	0.00149	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	3.65e-05	0.00148	CbGpPWpGaD
Lansoprazole—Vomiting—Triamcinolone—ulcerative colitis	3.64e-05	0.000187	CcSEcCtD
Lansoprazole—Vomiting—Methylprednisolone—ulcerative colitis	3.64e-05	0.000186	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	3.63e-05	0.00148	CbGpPWpGaD
Lansoprazole—Nausea—Hydrocortisone—ulcerative colitis	3.62e-05	0.000185	CcSEcCtD
Lansoprazole—Rash—Triamcinolone—ulcerative colitis	3.61e-05	0.000185	CcSEcCtD
Lansoprazole—Dermatitis—Triamcinolone—ulcerative colitis	3.61e-05	0.000185	CcSEcCtD
Lansoprazole—Rash—Methylprednisolone—ulcerative colitis	3.61e-05	0.000185	CcSEcCtD
Lansoprazole—Dermatitis—Methylprednisolone—ulcerative colitis	3.6e-05	0.000185	CcSEcCtD
Lansoprazole—Urticaria—Prednisone—ulcerative colitis	3.6e-05	0.000184	CcSEcCtD
Lansoprazole—Headache—Triamcinolone—ulcerative colitis	3.59e-05	0.000184	CcSEcCtD
Lansoprazole—Headache—Methylprednisolone—ulcerative colitis	3.58e-05	0.000184	CcSEcCtD
Lansoprazole—Body temperature increased—Prednisone—ulcerative colitis	3.58e-05	0.000184	CcSEcCtD
Lansoprazole—Abdominal pain—Prednisone—ulcerative colitis	3.58e-05	0.000184	CcSEcCtD
Lansoprazole—Diarrhoea—Dexamethasone—ulcerative colitis	3.56e-05	0.000182	CcSEcCtD
Lansoprazole—Diarrhoea—Betamethasone—ulcerative colitis	3.56e-05	0.000182	CcSEcCtD
Lansoprazole—CYP4A11—NRF2 pathway—TGFB1—ulcerative colitis	3.55e-05	0.00144	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	3.55e-05	0.00144	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DLD—ulcerative colitis	3.47e-05	0.00141	CbGpPWpGaD
Lansoprazole—Dizziness—Dexamethasone—ulcerative colitis	3.44e-05	0.000176	CcSEcCtD
Lansoprazole—Dizziness—Betamethasone—ulcerative colitis	3.44e-05	0.000176	CcSEcCtD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.43e-05	0.00139	CbGpPWpGaD
Lansoprazole—Nausea—Triamcinolone—ulcerative colitis	3.4e-05	0.000175	CcSEcCtD
Lansoprazole—Nausea—Methylprednisolone—ulcerative colitis	3.4e-05	0.000174	CcSEcCtD
Lansoprazole—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	3.36e-05	0.00137	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Prednisone—ulcerative colitis	3.34e-05	0.000171	CcSEcCtD
Lansoprazole—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3.33e-05	0.00135	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.31e-05	0.00135	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.31e-05	0.00135	CbGpPWpGaD
Lansoprazole—Vomiting—Dexamethasone—ulcerative colitis	3.31e-05	0.000169	CcSEcCtD
Lansoprazole—Vomiting—Betamethasone—ulcerative colitis	3.31e-05	0.000169	CcSEcCtD
Lansoprazole—Rash—Dexamethasone—ulcerative colitis	3.28e-05	0.000168	CcSEcCtD
Lansoprazole—Rash—Betamethasone—ulcerative colitis	3.28e-05	0.000168	CcSEcCtD
Lansoprazole—Dermatitis—Betamethasone—ulcerative colitis	3.28e-05	0.000168	CcSEcCtD
Lansoprazole—Dermatitis—Dexamethasone—ulcerative colitis	3.28e-05	0.000168	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	3.26e-05	0.00133	CbGpPWpGaD
Lansoprazole—Headache—Betamethasone—ulcerative colitis	3.26e-05	0.000167	CcSEcCtD
Lansoprazole—Headache—Dexamethasone—ulcerative colitis	3.26e-05	0.000167	CcSEcCtD
Lansoprazole—Asthenia—Prednisone—ulcerative colitis	3.25e-05	0.000167	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.22e-05	0.00131	CbGpPWpGaD
Lansoprazole—Pruritus—Prednisone—ulcerative colitis	3.2e-05	0.000164	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.13e-05	0.00127	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—PPARG—ulcerative colitis	3.11e-05	0.00126	CbGpPWpGaD
Lansoprazole—Diarrhoea—Prednisone—ulcerative colitis	3.1e-05	0.000159	CcSEcCtD
Lansoprazole—Nausea—Dexamethasone—ulcerative colitis	3.09e-05	0.000158	CcSEcCtD
Lansoprazole—Nausea—Betamethasone—ulcerative colitis	3.09e-05	0.000158	CcSEcCtD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	3.04e-05	0.00124	CbGpPWpGaD
Lansoprazole—Dizziness—Prednisone—ulcerative colitis	3e-05	0.000154	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism—CHP1—ulcerative colitis	2.97e-05	0.00121	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.93e-05	0.00119	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.93e-05	0.00119	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	2.91e-05	0.00118	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	2.9e-05	0.00118	CbGpPWpGaD
Lansoprazole—Vomiting—Prednisone—ulcerative colitis	2.88e-05	0.000148	CcSEcCtD
Lansoprazole—Rash—Prednisone—ulcerative colitis	2.86e-05	0.000146	CcSEcCtD
Lansoprazole—Dermatitis—Prednisone—ulcerative colitis	2.85e-05	0.000146	CcSEcCtD
Lansoprazole—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	2.84e-05	0.00116	CbGpPWpGaD
Lansoprazole—Headache—Prednisone—ulcerative colitis	2.84e-05	0.000145	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.78e-05	0.00113	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.72e-05	0.00111	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CHP1—ulcerative colitis	2.7e-05	0.0011	CbGpPWpGaD
Lansoprazole—Nausea—Prednisone—ulcerative colitis	2.69e-05	0.000138	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	2.65e-05	0.00108	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DLD—ulcerative colitis	2.56e-05	0.00104	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.54e-05	0.00103	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.54e-05	0.00103	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	2.47e-05	0.001	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	2.37e-05	0.000963	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2—ulcerative colitis	2.36e-05	0.000959	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DLD—ulcerative colitis	2.33e-05	0.000948	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.26e-05	0.00092	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.19e-05	0.000893	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.11e-05	0.00086	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.11e-05	0.00086	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.1e-05	0.000855	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	2.09e-05	0.000852	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS1—ulcerative colitis	1.92e-05	0.000782	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.89e-05	0.000769	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	1.84e-05	0.000748	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CHP1—ulcerative colitis	1.83e-05	0.000743	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CALM3—ulcerative colitis	1.73e-05	0.000704	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—ulcerative colitis	1.72e-05	0.000699	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.71e-05	0.000697	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.68e-05	0.000685	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS1—ulcerative colitis	1.68e-05	0.000683	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.68e-05	0.000682	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.65e-05	0.000673	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.58e-05	0.000644	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DLD—ulcerative colitis	1.58e-05	0.000642	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.57e-05	0.000639	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.57e-05	0.000639	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CALM3—ulcerative colitis	1.51e-05	0.000615	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.5e-05	0.000608	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CHP1—ulcerative colitis	1.46e-05	0.000594	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DLD—ulcerative colitis	1.45e-05	0.000588	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.4e-05	0.00057	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.38e-05	0.00056	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.36e-05	0.000555	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.35e-05	0.000551	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ABCB1—ulcerative colitis	1.35e-05	0.000547	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DLD—ulcerative colitis	1.29e-05	0.000525	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.28e-05	0.00052	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DLD—ulcerative colitis	1.26e-05	0.000513	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ADCY5—ulcerative colitis	1.26e-05	0.000511	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.26e-05	0.000511	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS1—ulcerative colitis	1.24e-05	0.000504	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.22e-05	0.000495	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DLD—ulcerative colitis	1.19e-05	0.000483	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DLD—ulcerative colitis	1.18e-05	0.000479	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ABCB1—ulcerative colitis	1.18e-05	0.000478	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.17e-05	0.000474	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.13e-05	0.000458	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CALM3—ulcerative colitis	1.11e-05	0.000454	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ADCY5—ulcerative colitis	1.1e-05	0.000446	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.09e-05	0.000444	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.09e-05	0.000443	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.07e-05	0.000433	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.05e-05	0.000429	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CALM3—ulcerative colitis	1.01e-05	0.000413	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DLD—ulcerative colitis	1.01e-05	0.000409	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PPARG—ulcerative colitis	9.36e-06	0.000381	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	9.07e-06	0.000369	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CHP1—ulcerative colitis	8.99e-06	0.000366	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCB1—ulcerative colitis	8.67e-06	0.000353	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.49e-06	0.000346	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	8.47e-06	0.000345	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—ulcerative colitis	8.42e-06	0.000342	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.34e-06	0.000339	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PPARG—ulcerative colitis	8.18e-06	0.000333	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ADCY5—ulcerative colitis	8.09e-06	0.000329	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ABCB1—ulcerative colitis	7.89e-06	0.000321	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DLD—ulcerative colitis	7.76e-06	0.000316	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.65e-06	0.000311	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS1—ulcerative colitis	7.63e-06	0.00031	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.5e-06	0.000305	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.47e-06	0.000304	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—ulcerative colitis	7.36e-06	0.0003	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ADCY5—ulcerative colitis	7.36e-06	0.000299	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—ulcerative colitis	7.36e-06	0.000299	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS1—ulcerative colitis	6.99e-06	0.000284	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.88e-06	0.00028	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CALM3—ulcerative colitis	6.87e-06	0.000279	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.83e-06	0.000278	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.56e-06	0.000267	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—ulcerative colitis	6.44e-06	0.000262	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.3e-06	0.000256	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.24e-06	0.000254	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.22e-06	0.000253	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.14e-06	0.00025	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.09e-06	0.000248	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—ulcerative colitis	6.03e-06	0.000245	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.02e-06	0.000245	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS1—ulcerative colitis	5.74e-06	0.000234	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.7e-06	0.000232	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.69e-06	0.000231	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.62e-06	0.000229	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.6e-06	0.000228	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—ulcerative colitis	5.49e-06	0.000223	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CALM3—ulcerative colitis	5.48e-06	0.000223	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—ulcerative colitis	5.42e-06	0.000221	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.37e-06	0.000218	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCB1—ulcerative colitis	5.34e-06	0.000217	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.32e-06	0.000216	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.17e-06	0.00021	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.12e-06	0.000208	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ADCY5—ulcerative colitis	4.98e-06	0.000203	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—ulcerative colitis	4.93e-06	0.000201	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.9e-06	0.000199	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.9e-06	0.000199	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS1—ulcerative colitis	4.86e-06	0.000198	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.78e-06	0.000195	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—ulcerative colitis	4.75e-06	0.000193	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.57e-06	0.000186	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.38e-06	0.000178	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.37e-06	0.000178	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.32e-06	0.000176	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.18e-06	0.00017	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.08e-06	0.000166	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.02e-06	0.000164	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—ulcerative colitis	3.98e-06	0.000162	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.98e-06	0.000162	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.75e-06	0.000153	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.75e-06	0.000153	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.72e-06	0.000151	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—ulcerative colitis	3.72e-06	0.000151	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.41e-06	0.000139	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.4e-06	0.000139	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.38e-06	0.000137	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—ulcerative colitis	3.34e-06	0.000136	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.18e-06	0.000129	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—ulcerative colitis	3.06e-06	0.000125	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.04e-06	0.000124	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—ulcerative colitis	2.97e-06	0.000121	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—ulcerative colitis	2.92e-06	0.000119	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.8e-06	0.000114	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.77e-06	0.000113	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—ulcerative colitis	2.73e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.68e-06	0.000109	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—ulcerative colitis	2.67e-06	0.000109	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.63e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—ulcerative colitis	2.51e-06	0.000102	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—ulcerative colitis	2.49e-06	0.000101	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.45e-06	9.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.39e-06	9.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.37e-06	9.64e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.33e-06	9.5e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.2e-06	8.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.18e-06	8.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—ulcerative colitis	2.13e-06	8.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.86e-06	7.58e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.83e-06	7.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—ulcerative colitis	1.64e-06	6.69e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.44e-06	5.85e-05	CbGpPWpGaD
